WO2004024762A3 - Proteine de type il-8 - Google Patents

Proteine de type il-8 Download PDF

Info

Publication number
WO2004024762A3
WO2004024762A3 PCT/GB2003/003957 GB0303957W WO2004024762A3 WO 2004024762 A3 WO2004024762 A3 WO 2004024762A3 GB 0303957 W GB0303957 W GB 0303957W WO 2004024762 A3 WO2004024762 A3 WO 2004024762A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
insp089
termed
diagnosis
disease
Prior art date
Application number
PCT/GB2003/003957
Other languages
English (en)
Other versions
WO2004024762A2 (fr
Inventor
Richard Joseph Fagan
Christopher Benjamin Phelps
Mark Douglas Davies
Christine Power
Original Assignee
Ares Trading Sa
Richard Joseph Fagan
Christopher Benjamin Phelps
Mark Douglas Davies
Christine Power
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa, Richard Joseph Fagan, Christopher Benjamin Phelps, Mark Douglas Davies, Christine Power filed Critical Ares Trading Sa
Priority to AU2003269122A priority Critical patent/AU2003269122A1/en
Publication of WO2004024762A2 publication Critical patent/WO2004024762A2/fr
Publication of WO2004024762A3 publication Critical patent/WO2004024762A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/5421IL-8
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/523Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention se rapporte à une nouvelle protéine, appelée INSP089, identifiée dans la description comme une protéine du type IL-8. L'invention se rapporte également à l'utilisation de cette protéine et d'une séquence d'acides nucléiques des gènes codants dans le diagnostic, la prévention et le traitement de maladies.
PCT/GB2003/003957 2002-09-12 2003-09-12 Proteine de type il-8 WO2004024762A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003269122A AU2003269122A1 (en) 2002-09-12 2003-09-12 Il-8 like protein

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0221145A GB0221145D0 (en) 2002-09-12 2002-09-12 Protein
GB0221145.6 2002-09-12

Publications (2)

Publication Number Publication Date
WO2004024762A2 WO2004024762A2 (fr) 2004-03-25
WO2004024762A3 true WO2004024762A3 (fr) 2004-05-27

Family

ID=9943918

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/003957 WO2004024762A2 (fr) 2002-09-12 2003-09-12 Proteine de type il-8

Country Status (3)

Country Link
AU (1) AU2003269122A1 (fr)
GB (1) GB0221145D0 (fr)
WO (1) WO2004024762A2 (fr)

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AN PING ET AL: "Modulating influence on HIV/AIDS by interacting RANTES gene variants", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 99, no. 15, 23 July 2002 (2002-07-23), July 23, 2002, pages 10002 - 10007, XP002272383, ISSN: 0027-8424 *
DATABASE EMBL [online] EBI; 25 July 2001 (2001-07-25), "homo sapiens BAC clone RP11-225M4", XP002272387, Database accession no. AC092619 *
DATABASE SWISSPROT [online] EBI; 1 January 1990 (1990-01-01), "SY05 human", XP002272386, Database accession no. P13501 *
DATABASE SWISSPROT [online] ebi; 1 May 2000 (2000-05-01), ADAMS ET AL.,: "cG9129 protein of drosophila melanogaster", XP002272388, Database accession no. Q9W0I5 *
HORIGUCHI HYOGO ET AL: "Cadmium-induced acute hepatic injury is exacerbated in human interleukin-8 transgenic mice", TOXICOLOGY AND APPLIED PHARMACOLOGY, vol. 163, no. 3, 15 March 2000 (2000-03-15), pages 231 - 239, XP002272384, ISSN: 0041-008X *
MICHALOVICH DAVID ET AL: "Protein sequence analysis in silico: Application of structure-based bioinformatics to genomic initiatives", CURRENT OPINION IN PHARMACOLOGY, vol. 2, no. 5, October 2002 (2002-10-01), pages 1 - 7, XP002272385, ISSN: 1471-4892 *
NOMIYAMA H ET AL: "Organization of the chemokine gene cluster on human chromosome 17q11.2 containing the genes for CC chemokine MPIF-1, HCC-2, HCC-1, LEC and RANTES", JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, MARY ANN LIEBERT, NEW YORK, NY, US, vol. 19, 1999, pages 227 - 234, XP002965394, ISSN: 1079-9907 *
OPPENHEIM J J ET AL: "PROPERTIES OF THE NOVEL PROINFLAMMATORY SUPERGENE INTERCRINE CYTOKINE FAMILY", ANNUAL REVIEW OF IMMUNOLOGY, ANNUAL REVIEWS INC, US, vol. 9, 1991, pages 617 - 648, XP000926599, ISSN: 0732-0582 *

Also Published As

Publication number Publication date
AU2003269122A8 (en) 2004-04-30
GB0221145D0 (en) 2002-10-23
AU2003269122A1 (en) 2004-04-30
WO2004024762A2 (fr) 2004-03-25

Similar Documents

Publication Publication Date Title
IL169367A0 (en) Defensin proteins
WO2006046073A3 (fr) Proteine du type c1q
WO2003054012A3 (fr) Leptines
WO2004076614A3 (fr) Sequences d'acide nucleique humaines issues de carcinomes de la prostate
WO2006016172A3 (fr) Glycoproteine de surface
WO2006043060A3 (fr) Proteine contenant le domaine mam
IL169256A0 (en) Metalloprotease proteins
WO2004016654A8 (fr) Proteine du type il-8
WO2004024762A3 (fr) Proteine de type il-8
WO2002070557A3 (fr) Domaine de liaison du ligand du recepteur hormonal nucleaire
WO2004009633A8 (fr) Recepteur de serotonine
WO2004053117A3 (fr) Serine protease
WO2004076613A3 (fr) Sequences d'acides nucleiques humaines provenant de carcinomes de la vessie
WO2004101618A3 (fr) Proteines associees au recepteur de progestine yol002c-cgi-45
WO2004050703A8 (fr) Variant d'epissage de l'hormone de croissance hypophysaire humaine
WO2004000882A3 (fr) Proteines
WO2002033058A3 (fr) Proteases a cysteine
WO2002062845A3 (fr) Molecules d'adhesion
WO2004026905A3 (fr) Proteines de transport/canal
WO2003100061A3 (fr) Proteine repliee de toxine a trois doigts
WO2004081170A3 (fr) Proteine de type recepteur de la progestine
WO2007049062A3 (fr) Protéines contenant des domaines vwfa
WO2003066844A3 (fr) Proteine p450 cytochrome
WO2004003011A3 (fr) Recepteur hormonal nucleaire
WO2002029023A8 (fr) Proteine appelee nicastrine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP